ABHIJEET BASOOR

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease TACOMA, WA NPI 1194993147

General Payments — all program years on this page

$3,021.34

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 178
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $421.70 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $421.7020

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $452.4235
2019 $795.5543
2020 $186.6011
2021 $27.932
2022 $410.5125
2023 $726.6342
2024 $421.7020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078085398 Janssen Pharmaceuticals, Inc $22.76 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078899073 Actelion Pharmaceuticals US, Inc. $17.21 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081718860 Lexicon Pharmaceuticals, Inc. $17.83 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082355869 Tactile Systems Technology Inc $14.24 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086714743 Novartis Pharmaceuticals Corporation $16.25 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092582763 Boston Scientific Corporation $27.29 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096667239 Novo Nordisk Inc $17.99 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097676546 Novo Nordisk Inc $19.83 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111525730 Amgen Inc. $26.37 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120648222 Baxter Healthcare $14.33 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131615922 PFIZER INC. $14.53 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131615926 PFIZER INC. $16.62 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131615930 PFIZER INC. $13.35 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140061336 Inari Medical, Inc. $34.27 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141649525 Merck Sharp & Dohme LLC $14.86 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141649527 Merck Sharp & Dohme LLC $19.89 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141853009 Merck Sharp & Dohme LLC $17.40 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142282807 ABIOMED $46.59 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149451479 United Therapeutics Corporation $31.14 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154895068 Kiniksa Pharmaceuticals International, plc $18.95 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.